# Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee

> **NCT00904605** · PHASE4 · TERMINATED · sponsor: **Endo Pharmaceuticals**

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** Lidoderm
- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT00904605
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-06
- **Primary completion:** 2004-11
- **Final completion:** 2004-11
- **Target enrollment:** — (—)
- **Why stopped:** Safety concerns with the COX-2 specific inhibitor class of drug.
- **Last updated:** 2010-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00904605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00904605, "Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00904605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*